Table 2.
MSI‐H | MSS | P | |
---|---|---|---|
n = 121 (%) | n = 2098 (%) | ||
Gender | |||
Female | 70 (7.7) | 841 (92.3) | <0.001 |
Male | 51 (3.9) | 1257 (96.1) | |
Age at diagnosis of CRC | |||
Mean ± SD | 68.1 ± 9.56 | 66.4 ± 8.44 | 0.07 |
Location | |||
Proximal | 86 (12.9) | 582 (87.1) | <0.001 |
Distal | 35 (2.3) | 1516 (97.7) | |
Tumor size | |||
Mean ± SD(mm) | 58.3 ± 35.9 | 44.6 ± 22.5 | <0.001 |
TNM stage | |||
0‐I | 28 (5.6) | 471 (94.4) | <0.001 |
62 (8.8) | 642 (91.2) | ||
21 (3.2) | 635 (96.8) | ||
10 (2.8) | 350 (97.2) | ||
Mucinous component | |||
− | 79 (4.1) | 1868 (95.9) | <0.001 |
+ | 42 (15.4) | 230 (84.6) | |
KRAS | |||
Wild | 82 (6.5) | 1183 (93.5) | 0.01 |
Mutant | 39 (4.1) | 915 (95.9) | |
BRAF | |||
Wild | 75 (3.5) | 2046 (96.5) | <0.001 |
Mutant | 46 (46.9) | 52 (53.1) |
Proximal, cecum to transverse colon; Distal, splenic flexure to rectum; TNM, tumor node metastasis; MSI‐H, high‐frequency microsatellite instability; MSS, microsatellite stable.